Horizon Wealth Management LLC Increases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Horizon Wealth Management LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.5% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,177 shares of the healthcare conglomerate’s stock after buying an additional 51 shares during the quarter. Horizon Wealth Management LLC’s holdings in UnitedHealth Group were worth $582,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Tealwood Asset Management Inc. lifted its position in UnitedHealth Group by 0.4% during the 4th quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock worth $2,626,000 after acquiring an additional 19 shares during the period. Atlas Private Wealth Advisors lifted its position in UnitedHealth Group by 1.1% during the 4th quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock worth $923,000 after acquiring an additional 19 shares during the period. Prentice Wealth Management LLC lifted its position in UnitedHealth Group by 0.8% during the 4th quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock worth $1,235,000 after acquiring an additional 19 shares during the period. Baker Avenue Asset Management LP lifted its position in UnitedHealth Group by 1.7% during the 3rd quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock worth $615,000 after acquiring an additional 20 shares during the period. Finally, Granite Harbor Advisors Inc. lifted its position in UnitedHealth Group by 2.9% during the 3rd quarter. Granite Harbor Advisors Inc. now owns 718 shares of the healthcare conglomerate’s stock worth $362,000 after acquiring an additional 20 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $494.43 on Tuesday. The stock has a fifty day moving average of $498.34 and a two-hundred day moving average of $501.63. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market capitalization of $455.07 billion, a price-to-earnings ratio of 30.22, a PEG ratio of 1.48 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter in the previous year, the business earned $6.26 earnings per share. The firm’s quarterly revenue was up 8.6% compared to the same quarter last year. On average, analysts anticipate that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were given a $2.10 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.70%. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Piper Sandler increased their target price on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 target price for the company in a research note on Wednesday, June 5th. Morgan Stanley cut their target price on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research note on Friday, April 5th. Barclays increased their target price on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Finally, Royal Bank of Canada dropped their price objective on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday, April 17th. Three investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.